President Trump is reportedly working on another executive order targeting rising drug prices, according to Reuters. The action is specifically taking aim at reducing Medicare drug prices, cutting virtually branded prescription drugs sold to the federal program, sources told Reuters.

Trump has already drafted executive orders taking rising healthcare costs into the hands of the White House. Recently, Trump was reported to be working on an order to declare a favored nations clause for drug prices, which would ensure the U.S. did not pay higher prices than other countries for medications. Another recent order requires hospitals and insurers to disclose negotiated rates for healthcare services and give patients their out-of-pocket costs before procedures.

The newest order goes much further than HHS actions to lower drug prices, which include a recent proposed rule to lower prices for Medicare Part B drugs, which are typically administered in a physician’s office.

See the full story below: